vs
BRIGHT HORIZONS FAMILY SOLUTIONS INC.（BFAM）とペナンブラ（PEN）の財務データ比較。上の社名をクリックして会社を切り替えられます
BRIGHT HORIZONS FAMILY SOLUTIONS INC.の直近四半期売上が大きい（$733.7M vs $385.4M、ペナンブラの約1.9倍）。ペナンブラの前年同期比売上増加率が高い（22.1% vs 8.8%）。BRIGHT HORIZONS FAMILY SOLUTIONS INC.の直近四半期フリーキャッシュフローが多い（$258.5M vs $68.0M）。過去8四半期でペナンブラの売上複合成長率が高い（17.6% vs 8.5%）
Bright Horizons Family Solutions Inc.は米国マサチューセッツ州ニュートンに本社を置く保育サービス事業者で、米国最大の企業主導型保育サービス提供会社です。予備保育・高齢者介護・授業料管理プログラム・教育アドバイス・学生ローン返済支援などのサービスも展開しています。
ペナンブラ社は2004年にArani BoseとAdam Elsesserによって設立された米国の医療機器メーカーで、本社はカリフォルニア州アラメダに所在します。脳卒中や動脈瘤などの血管疾患向けの介入治療用機器の開発・製造を主力事業として展開しています。
BFAM vs PEN — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $733.7M | $385.4M |
| 純利益 | — | $47.3M |
| 粗利率 | 19.3% | 68.0% |
| 営業利益率 | 6.2% | 15.4% |
| 純利益率 | — | 12.3% |
| 売上前年比 | 8.8% | 22.1% |
| 純利益前年比 | — | 40.6% |
| EPS（希薄化後） | $0.38 | $1.20 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $733.7M | $385.4M | ||
| Q3 25 | $802.8M | $354.7M | ||
| Q2 25 | $731.6M | $339.5M | ||
| Q1 25 | $665.5M | $324.1M | ||
| Q4 24 | $674.1M | $315.5M | ||
| Q3 24 | $719.1M | $301.0M | ||
| Q2 24 | $670.1M | $299.4M | ||
| Q1 24 | $622.7M | $278.7M |
| Q4 25 | — | $47.3M | ||
| Q3 25 | $78.6M | $45.9M | ||
| Q2 25 | $54.8M | $45.3M | ||
| Q1 25 | $38.0M | $39.2M | ||
| Q4 24 | — | $33.7M | ||
| Q3 24 | $54.9M | $29.5M | ||
| Q2 24 | $39.2M | $-60.2M | ||
| Q1 24 | $17.0M | $11.0M |
| Q4 25 | 19.3% | 68.0% | ||
| Q3 25 | 27.0% | 67.8% | ||
| Q2 25 | 25.0% | 66.0% | ||
| Q1 25 | 23.4% | 66.6% | ||
| Q4 24 | 20.8% | 66.8% | ||
| Q3 24 | 25.2% | 66.5% | ||
| Q2 24 | 24.2% | 54.4% | ||
| Q1 24 | 21.7% | 65.0% |
| Q4 25 | 6.2% | 15.4% | ||
| Q3 25 | 15.1% | 13.8% | ||
| Q2 25 | 11.8% | 12.0% | ||
| Q1 25 | 9.4% | 12.4% | ||
| Q4 24 | 7.2% | 13.6% | ||
| Q3 24 | 12.4% | 11.7% | ||
| Q2 24 | 10.3% | -27.0% | ||
| Q1 24 | 6.4% | 4.3% |
| Q4 25 | — | 12.3% | ||
| Q3 25 | 9.8% | 12.9% | ||
| Q2 25 | 7.5% | 13.3% | ||
| Q1 25 | 5.7% | 12.1% | ||
| Q4 24 | — | 10.7% | ||
| Q3 24 | 7.6% | 9.8% | ||
| Q2 24 | 5.8% | -20.1% | ||
| Q1 24 | 2.7% | 3.9% |
| Q4 25 | $0.38 | $1.20 | ||
| Q3 25 | $1.37 | $1.17 | ||
| Q2 25 | $0.95 | $1.15 | ||
| Q1 25 | $0.66 | $1.00 | ||
| Q4 24 | $0.50 | $0.88 | ||
| Q3 24 | $0.94 | $0.75 | ||
| Q2 24 | $0.67 | $-1.55 | ||
| Q1 24 | $0.29 | $0.28 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $140.1M | $186.9M |
| 総負債低いほど良い | $747.6M | — |
| 株主資本純資産 | $1.3B | $1.4B |
| 総資産 | $3.9B | $1.8B |
| 負債/資本比率低いほどレバレッジが低い | 0.56× | — |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $140.1M | $186.9M | ||
| Q3 25 | $116.6M | $321.0M | ||
| Q2 25 | $179.2M | $421.8M | ||
| Q1 25 | $112.0M | $376.1M | ||
| Q4 24 | $110.3M | $324.4M | ||
| Q3 24 | $109.9M | $280.5M | ||
| Q2 24 | $140.2M | $288.3M | ||
| Q1 24 | $63.7M | $223.1M |
| Q4 25 | $747.6M | — | ||
| Q3 25 | $747.5M | — | ||
| Q2 25 | $797.0M | — | ||
| Q1 25 | $872.7M | — | ||
| Q4 24 | $918.4M | — | ||
| Q3 24 | $925.7M | — | ||
| Q2 24 | $931.9M | — | ||
| Q1 24 | $938.1M | — |
| Q4 25 | $1.3B | $1.4B | ||
| Q3 25 | $1.4B | $1.4B | ||
| Q2 25 | $1.4B | $1.3B | ||
| Q1 25 | $1.3B | $1.2B | ||
| Q4 24 | $1.3B | $1.2B | ||
| Q3 24 | $1.4B | $1.1B | ||
| Q2 24 | $1.3B | $1.2B | ||
| Q1 24 | $1.2B | $1.2B |
| Q4 25 | $3.9B | $1.8B | ||
| Q3 25 | $3.9B | $1.7B | ||
| Q2 25 | $3.9B | $1.7B | ||
| Q1 25 | $3.8B | $1.6B | ||
| Q4 24 | $3.9B | $1.5B | ||
| Q3 24 | $3.9B | $1.5B | ||
| Q2 24 | $3.8B | $1.5B | ||
| Q1 24 | $3.8B | $1.6B |
| Q4 25 | 0.56× | — | ||
| Q3 25 | 0.52× | — | ||
| Q2 25 | 0.57× | — | ||
| Q1 25 | 0.66× | — | ||
| Q4 24 | 0.72× | — | ||
| Q3 24 | 0.66× | — | ||
| Q2 24 | 0.73× | — | ||
| Q1 24 | 0.76× | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $350.7M | $86.5M |
| フリーキャッシュフロー営業CF - 設備投資 | $258.5M | $68.0M |
| FCFマージンFCF / 売上 | 35.2% | 17.7% |
| 設備投資強度設備投資 / 売上 | 12.6% | 4.8% |
| キャッシュ転換率営業CF / 純利益 | — | 1.83× |
| 直近12ヶ月FCF直近4四半期 | $402.4M | $174.9M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $350.7M | $86.5M | ||
| Q3 25 | $-17.6M | $58.3M | ||
| Q2 25 | $134.2M | $44.9M | ||
| Q1 25 | $86.2M | $49.0M | ||
| Q4 24 | $337.5M | $51.1M | ||
| Q3 24 | $-8.9M | $56.5M | ||
| Q2 24 | $109.4M | $22.6M | ||
| Q1 24 | $116.3M | $38.3M |
| Q4 25 | $258.5M | $68.0M | ||
| Q3 25 | $-42.4M | $42.0M | ||
| Q2 25 | $115.4M | $29.4M | ||
| Q1 25 | $70.9M | $35.5M | ||
| Q4 24 | $240.2M | $45.7M | ||
| Q3 24 | $-32.2M | $51.0M | ||
| Q2 24 | $86.8M | $18.1M | ||
| Q1 24 | $96.9M | $32.5M |
| Q4 25 | 35.2% | 17.7% | ||
| Q3 25 | -5.3% | 11.8% | ||
| Q2 25 | 15.8% | 8.7% | ||
| Q1 25 | 10.7% | 11.0% | ||
| Q4 24 | 35.6% | 14.5% | ||
| Q3 24 | -4.5% | 16.9% | ||
| Q2 24 | 13.0% | 6.0% | ||
| Q1 24 | 15.6% | 11.7% |
| Q4 25 | 12.6% | 4.8% | ||
| Q3 25 | 3.1% | 4.6% | ||
| Q2 25 | 2.6% | 4.6% | ||
| Q1 25 | 2.3% | 4.2% | ||
| Q4 24 | 14.4% | 1.7% | ||
| Q3 24 | 3.2% | 1.8% | ||
| Q2 24 | 3.4% | 1.5% | ||
| Q1 24 | 3.1% | 2.1% |
| Q4 25 | — | 1.83× | ||
| Q3 25 | -0.22× | 1.27× | ||
| Q2 25 | 2.45× | 0.99× | ||
| Q1 25 | 2.26× | 1.25× | ||
| Q4 24 | — | 1.52× | ||
| Q3 24 | -0.16× | 1.91× | ||
| Q2 24 | 2.79× | — | ||
| Q1 24 | 6.85× | 3.48× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
BFAM
セグメントデータなし
PEN
| Thrombectomy | $254.7M | 66% |
| Other | $130.7M | 34% |
